BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30706688)

  • 21. Prognostic significance of the extent of visceral pleural invasion in completely resected node-negative non-small cell lung cancer.
    Hung JJ; Jeng WJ; Hsu WH; Chou TY; Lin SF; Wu YC
    Chest; 2012 Jul; 142(1):141-150. PubMed ID: 22241763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database.
    Yoshida J; Nagai K; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Aug; 4(8):959-63. PubMed ID: 19458555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.
    Samayoa AX; Pezzi TA; Pezzi CM; Greer Gay E; Asai M; Kulkarni N; Carp N; Chun SG; Putnam JB
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1005-1011. PubMed ID: 27531307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral pleural invasion classification in non-small cell lung cancer.
    Kawase A; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
    J Thorac Oncol; 2010 Nov; 5(11):1784-8. PubMed ID: 20881646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
    Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
    Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
    Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.
    Ludwig MS; Goodman M; Miller DL; Johnstone PA
    Chest; 2005 Sep; 128(3):1545-50. PubMed ID: 16162756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Level of pleural invasion effects on prognosis in lung cancer.
    Tanju S; Erus S; Selçukbiricik F; İliaz S; Kapdağlı M; Bulutay P; Sevinç TE; Mandel NM; Dilege Ş
    Tumori; 2019 Apr; 105(2):155-160. PubMed ID: 30165792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
    Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.
    Yu Y; Huang R; Wang P; Wang S; Ling X; Zhang P; Yu J; Wang J; Xiao J; Wang Z
    J Thorac Dis; 2020 Mar; 12(3):592-604. PubMed ID: 32274125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis.
    Jiang L; Liang W; Shen J; Chen X; Shi X; He J; Yang C; He J
    Chest; 2015 Oct; 148(4):903-911. PubMed ID: 25675151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.
    Shimizu K; Yoshida J; Nagai K; Nishimura M; Yokose T; Ishii G; Nishiwaki Y
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1574-8. PubMed ID: 15173709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis After Sublobar Resection of Small-sized Non-small Cell Lung Cancer with Visceral Pleural or Lymphovascular Invasion.
    Moon Y; Lee KY; Park JK
    World J Surg; 2017 Nov; 41(11):2769-2777. PubMed ID: 28597091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of visceral pleural invasion with skip N2 metastasis on clinical stage IA NSCLC.
    Minamoto F; Araújo P; D'Ambrosio P; Dela Vega A; Lauricella L; Pêgo-Fernandes P; Terra R
    Clinics (Sao Paulo); 2024; 79():100334. PubMed ID: 38484584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
    Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
    Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer.
    Travis WD; Brambilla E; Rami-Porta R; Vallières E; Tsuboi M; Rusch V; Goldstraw P;
    J Thorac Oncol; 2008 Dec; 3(12):1384-90. PubMed ID: 19057261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The modification of T description according to visceral pleural invasion and tumor size from 3.1 cm to 4.0 cm in non-small cell lung cancer: A retrospective analysis based on the SEER database.
    Qi M; Bian D; Zhang J; Zhu X; Zhou C; Zhang L
    Lung Cancer; 2021 Aug; 158():47-54. PubMed ID: 34119932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of visceral pleural invasion in the forthcoming (seventh) edition of TNM classification for lung cancer.
    Shim HS; Park IK; Lee CY; Chung KY
    Lung Cancer; 2009 Aug; 65(2):161-5. PubMed ID: 19128855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.